Twinbeech Capital LP Celldex Therapeutics, Inc. Transaction History

Twinbeech Capital LP

  • $5.52 Billion
  • Q4 2024

A detailed history of Twinbeech Capital LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Twinbeech Capital LP holds 34,558 shares of CLDX stock, worth $719,843. This represents 0.02% of its overall portfolio holdings.

Number of Shares
34,558
Previous 140,502 75.4%
Holding current value
$719,843
Previous $4.77 Million 81.71%
% of portfolio
0.02%
Previous 0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$23.31 - $32.4 $2.47 Million - $3.43 Million
-105,944 Reduced 75.4%
34,558 $873,000
Q3 2024

Nov 14, 2024
BUY
$32.06 - $44.56 $3.32 Million - $4.61 Million
103,497 Added 279.68%
140,502 $4.77 Million
Q2 2024

Aug 14, 2024
BUY
$32.76 - $42.56 $604,716 - $785,615
18,459 Added 99.53%
37,005 $1.37 Million
Q1 2024

May 15, 2024
SELL
$35.22 - $51.88 $656,183 - $966,576
-18,631 Reduced 50.11%
18,546 $778,000
Q4 2023

Feb 14, 2024
SELL
$22.61 - $40.65 $574,429 - $1.03 Million
-25,406 Reduced 40.6%
37,177 $1.47 Million
Q3 2023

Nov 14, 2023
BUY
$25.45 - $37.46 $1.13 Million - $1.66 Million
44,207 Added 240.57%
62,583 $1.72 Million
Q2 2023

Aug 14, 2023
SELL
$30.29 - $38.28 $778,210 - $983,489
-25,692 Reduced 58.3%
18,376 $623,000
Q1 2023

May 15, 2023
BUY
$34.78 - $47.43 $1.53 Million - $2.09 Million
44,068 New
44,068 $1.59 Million
Q3 2022

Nov 14, 2022
BUY
$22.7 - $37.57 $1.11 Million - $1.84 Million
48,939 New
48,939 $1.38 Million
Q2 2022

Aug 15, 2022
SELL
$20.5 - $37.33 $202,294 - $368,372
-9,868 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$27.64 - $39.32 $75,291 - $107,107
2,724 Added 38.13%
9,868 $336,000
Q4 2021

Feb 14, 2022
BUY
$35.68 - $56.27 $254,897 - $401,992
7,144 New
7,144 $276,000

Others Institutions Holding CLDX

# of Institutions
200
Shares Held
60.6M
Call Options Held
960K
Put Options Held
675K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $974M
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email